{"title":"American Academy of Neurology (AAN) - 74th Annual Meeting: The Great Neuro Reunion. Seattle - April 2-7, 2022","authors":"J. Polychrones","doi":"10.1358/dof.2022.47.6.3435136","DOIUrl":null,"url":null,"abstract":"The 2022 American Academy of Neurology (AAN) annual meeting returned to in-person attendance for the first time in 2 years since the COVID-19 public health emergency began. AAN is the largest association of neurologists and neuroscience professionals with over 38,000 members. This meeting included plenary sessions and over 2,400 scientific s highlighting the latest scientific advancements in brain disease. Research and clinical trial updates were provided in many specific disease areas, including Parkinson???s, Huntington???s, amyotrophic lateral sclerosis, migraine, multiple sclerosis, epilepsy, narcolepsy, Alzheimer???s, and so on. Along with groundbreaking research in neurology, many presentations included the impact of COVID-19 on patients with these diseases and ongoing neurology clinical trials. This report highlights a selection of presentations about treatment updates provided during the conference.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"39 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs of The Future","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1358/dof.2022.47.6.3435136","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
The 2022 American Academy of Neurology (AAN) annual meeting returned to in-person attendance for the first time in 2 years since the COVID-19 public health emergency began. AAN is the largest association of neurologists and neuroscience professionals with over 38,000 members. This meeting included plenary sessions and over 2,400 scientific s highlighting the latest scientific advancements in brain disease. Research and clinical trial updates were provided in many specific disease areas, including Parkinson???s, Huntington???s, amyotrophic lateral sclerosis, migraine, multiple sclerosis, epilepsy, narcolepsy, Alzheimer???s, and so on. Along with groundbreaking research in neurology, many presentations included the impact of COVID-19 on patients with these diseases and ongoing neurology clinical trials. This report highlights a selection of presentations about treatment updates provided during the conference.
期刊介绍：
A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions.
The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
